Mobia Medical, Inc. Common Stock (MOBI) Stock
NYSE · MOBI
10.54
Fundamentals
Market cap
$350.89M
Price / Earnings ratio
-7.8x
Price / Sales ratio
11.3x
Price / Book ratio
2.1x
Return on assets
N/A
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Mobia Medical, Inc. Common Stock
Mobia Medical is a commercial-stage medical device company focused on stroke recovery solutions for patients with long-term motor impairments. Its Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the first FDA-approved, clinically validated therapy designed for chronic ischemic stroke survivors experiencing moderate to severe upper extremity impairment. Stroke remains one of the leading causes of long-term disability in the United States.
SectorHealthcare
IndustryMedical Devices
Employees167
CEOMr. Richard John Foust
IPO DateMay 8, 2026
HeadquartersAustin, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard John Foust | CEO, President & Director | 1974 |
| Mr. Thomas Jordan Curnes II, M.B.A. | Co-Founder | 1979 |
| Mr. Nelson Bunker Curnes | Chief Financial Officer | 1983 |
| Mr. Prashant B. Rawat | Chief Operating Officer | 1974 |
| Mr. Douglas T. Ellison | Chief Commercial Officer | 1963 |
| Dr. Navzer Engineer M.D., Ph.D. | Co-Founder & Chief Scientific Officer | — |
| Mr. Chase C. Leavitt J.D. | General Counsel & Corporate Secretary | 1982 |
| Mr. Philip B. Freed | Vice President of Marketing | — |
| Ms. Steffanie Cook | Vice President of Human Resources | — |
Fundamentals
Valuation
Market cap$350.89M
Price-to-sales ratio11.28
Price-to-book value2.09
Price-earnings ratio-7.80
Return on EquityN/A
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-54.78
Income Statement
Average volume176,571
EBITDA$-45.37M
1 year high (52w)$15.29
1 year low (52w)$9.85
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



